Nerve Stimulators Market Research Report - Forecast till 2030

Nerve Stimulators Market Research Report Information By Type (Deep Brain Stimulator, Vagus Nerve Stimulator and Spinal Cord Stimulator), Applications (Chronic Pain, Depression, Dystonia, Epilepsy and Parkinson’s Disease), End User (Ambulatory Surgical Centers, Hospital & Clinics and Trauma Centers) - Forecast till 2030

ID: MRFR/MED/3820-CR | 102 Pages | Author: Rahul Gotadki | July 2019         

1 Report Prologue

2 Market Introduction

2.1 Research Objective 13

2.2 Assumptions & Limitations 13

2.2.1 Assumptions 13

2.2.2 Limitations 13

3 Research Methodology

3.1 Research Process 15

3.2 Primary Research 16

3.3 Secondary Research 16

3.4 Market Size Estimation 17

4 Market Dynamics

4.1 Introduction 19

4.2 Drivers 20

4.2.1 Rising Incidence Of Chronic Health Problems (Impact Weightage: 35%) 20

4.2.2 Technological Improvements (Impact Weightage: 35%) 21

4.2.3 Increasing Geriatric Population (Impact Weightage: 20%) 22

4.2.4 Improved Reimbursement Policies In Developed Countries (Impact Weightage: 10%) 23

4.3 Restrains 24

4.3.1 Lack Of Skilled Or Trained Physicians (Impact Weightage: 60%) 24

4.3.2 High Cost Of Nerve Stimulation Therapy (Impact Weightage: 40%) 25

4.4 Opportunity 26

4.4.1 Increasing Popularity Of Minimally Invasive Procedures Across The Globe 26

4.5 Macroeconomic Indicators 26

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 27

5.1.1 Bargaining Power Of Suppliers 27

5.1.2 Bargaining Power Of Buyers 28

5.1.3 Threat On New Entrants 28

5.1.4 Threat Of Substitutes 28

5.1.5 Intensity Of Rivalry 28

5.2 Value Chain Analysis 29

5.2.1 R&D And Designing 29

5.2.2 Manufacturing 29

5.2.3 Distribution & Sales 30

5.2.4 Post-Sales Monitoring 30

5.3 Demand & Supply: Gap Analysis 31

5.4 Pricing Analysis 31

6 Global Nerve Stimulator Market By Type

6.1 Introduction 32

6.2 Deep Brain Stimulator (DBS) 33

6.3 Vagus Nerve Stimulator (VNS) 34

6.4 Spinal Cord Stimulator (SCS) 34

7 Global Nerve Stimulator Market By Applications

7.1 Introduction 35

7.2 Chronic Pain 36

7.3 Depression 37

7.4 Dystonia 37

7.5 Epilepsy 38

7.6 Parkinson’s Disease 38

8 Global Nerve Stimulator Market By End User

8.1 Introduction 39

8.2 Ambulatory Surgical Centers 40

8.3 Hospital & Clinics 41

8.4 Trauma Centers 41

9 Global Nerve Stimulator Market By Regions

9.1 Introduction 42

9.2 Americas 43

9.2.1 North America 46

9.2.1.1 US 47

9.2.1.2 Canada 49

9.2.2 South America 50

9.3 Europe 52

9.3.1 Western Germany 54

9.3.1.1 Germany 56

9.3.1.2 France 57

9.3.1.3 Italy 59

9.3.1.4 Spain 60

9.3.1.5 UK 62

9.3.1.6 Rest Of Western Europe 63

9.3.2 Eastern Europe 65

9.4 Asia-Pacific 67

9.4.1 China 69

9.4.2 India 71

9.4.3 Japan 72

9.4.4 South Korea 74

9.4.5 Australia 75

9.4.6 Rest Of Asia-Pacific 77

9.5 Middle East & Africa 79

9.5.1 UAE 81

9.5.2 Saudi Arabia 83

9.5.3 Oman 84

9.5.4 Kuwait 86

9.5.5 Qatar 87

9.5.6 Rest Of Middle East & Africa 89

10 Competitive Landscape

10.1 Introduction 91

11 Company Profile

11.1 Boston Scientific Corporation 92

11.1.1 Company Overview 92

11.1.2 Financials 92

11.1.3 Products 92

11.1.4 Strategy 92

11.1.5 Key Developments 92

11.2 Cochlear Ltd 93

11.2.1 Company Overview 93

11.2.2 Financials 93

11.2.3 Products 93

11.2.4 Strategy 93

11.2.5 Key Developments 93

11.3 Medtronic 94

11.3.1 Company Overview 94

11.3.2 Financials 94

11.3.3 Products 94

11.3.4 Strategy 94

11.3.5 Key Developments 94

11.4 St Jude Medical, Inc. 95

11.4.1 Company Overview 95

11.4.2 Financials 95

11.4.3 Products 95

11.4.4 Strategy 95

11.4.5 Key Developments 95

11.5 Cyberonics, Inc. 96

11.5.1 Company Overview 96

11.5.2 Financials 96

11.5.3 Products 96

11.5.4 Strategy 96

11.5.5 Key Developments 96

11.6 Aleva Neurotherapeutics SA 97

11.6.1 Company Overview 97

11.6.2 Financials 97

11.6.3 Products 97

11.6.4 Strategy 97

11.6.5 Key Developments 97

11.7 NeuroPace, Inc. 98

11.7.1 Company Overview 98

11.7.2 Financials 98

11.7.3 Products 98

11.7.4 Strategy 98

11.7.5 Key Developments 98

12 Conclusion

12.1 Key Findings 99

12.1.1 From CEO’s View Point 99

12.2 Key Companies To Watch 99

13 Appendix

13.1 Discussion Blue Print 100

14 List Of Tables

TABLE 1 GLOBAL NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 32

TABLE 2 GLOBAL NERVE STIMULATOR MARKET FOR DEEP BRAIN STIMULATOR (DBS) USD MILLION (2020–2027) 33

TABLE 3 GLOBAL NERVE STIMULATOR MARKET FOR SPINAL CORD STIMULATOR (SCS) USD MILLION (2020–2027) 34

TABLE 4 GLOBAL NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 35

TABLE 5 GLOBAL NERVE STIMULATOR MARKET FOR CHRONIC PAIN USD MILLION (2020–2027) 36

TABLE 6 GLOBAL NERVE STIMULATOR MARKET FOR DEPRESSION USD MILLION (2020–2027) 37

TABLE 7 GLOBAL NERVE STIMULATOR MARKET FOR DYSTONIA USD MILLION (2020–2027) 37

TABLE 8 GLOBAL NERVE STIMULATOR MARKET FOR EPILEPSY USD MILLION (2020–2027) 38

TABLE 9 GLOBAL NERVE STIMULATOR MARKET FOR PARKINSON’S DISEASE USD MILLION (2020–2027) 38

TABLE 10 GLOBAL NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 39

TABLE 11 GLOBAL NERVE STIMULATOR MARKET FOR AMBULATORY SURGICAL CENTERS USD MILLION (2020–2027) 40

TABLE 12 GLOBAL NERVE STIMULATOR MARKET FOR HOSPITAL & CLINICS USD MILLION (2020–2027) 41

TABLE 13 GLOBAL NERVE STIMULATOR MARKET FOR HOSPITAL & CLINICS USD MILLION (2020–2027) 41

TABLE 14 GLOBAL NERVE STIMULATOR MARKET BY REGIONS USD MILLION (2020–2027) 42

TABLE 15 AMERICAS NERVE STIMULATOR MARKET BY REGIONS USD MILLION (2020–2027) 43

TABLE 16 AMERICAS NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 44

TABLE 17 AMERICAS NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 45

TABLE 18 AMERICAS NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 45

TABLE 19 NORTH AMERICA NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 46

TABLE 20 NORTH AMERICA NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 46

TABLE 21 NORTH AMERICA NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 47

TABLE 22 US NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 47

TABLE 23 US NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 48

TABLE 24 US NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 48

TABLE 25 CANADA NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 49

TABLE 26 CANADA NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 49

TABLE 27 CANADA NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 50

TABLE 28 SOUTH AMERICA NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 50

TABLE 29 SOUTH AMERICA NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 51

TABLE 30 SOUTH AMERICA NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 51

TABLE 31 EUROPE NERVE STIMULATOR MARKET BY REGIONS USD MILLION (2020–2027) 52

TABLE 32 EUROPE NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 53

TABLE 33 EUROPE NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 53

TABLE 34 EUROPE NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 54

TABLE 35 WESTERN EUROPE NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 54

TABLE 36 WESTERN EUROPE NERVE STIMULATOR MARKET BY APPLICATIONS USD MILLION (2020–2027) 55

TABLE 37 WESTERN EUROPE NERVE STIMULATOR MARKET BY END USER USD MILLION (2020–2027) 55

TABLE 38 GERMANY NERVE STIMULATOR MARKET BY TYPE USD MILLION (2020–2027) 56

TABLE 39 GERMANY NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 56

TABLE 40 GERMANY NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 57

TABLE 41 FRANCE NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 57

TABLE 42 FRANCE NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 58

TABLE 43 FRANCE NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 58

TABLE 44 ITALY NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 59

TABLE 45 ITALY NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 59

TABLE 46 ITALY NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 60

TABLE 47 SPAIN NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 60

TABLE 48 SPAIN NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 61

TABLE 49 SPAIN NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 61

TABLE 50 UK NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 62

TABLE 51 UK NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 62

TABLE 52 UK NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 63

TABLE 53 REST OF WESTERN EUROPE NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 63

TABLE 54 REST OF WESTERN EUROPE NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 64

TABLE 55 REST OF WESTERN EUROPE NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 64

TABLE 56 EASTERN EUROPE NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 65

TABLE 57 EASTERN EUROPE NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 65

TABLE 58 EASTERN EUROPE NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 66

TABLE 59 ASIA-PACIFIC NERVE STIMULATOR MARKET: BY REGIONS USD MILLION (2020–2027) 67

TABLE 60 ASIA-PACIFIC NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 68

TABLE 61 ASIA-PACIFIC NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 68

TABLE 62 ASIA-PACIFIC NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 69

TABLE 63 CHINA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 69

TABLE 64 CHINA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 70

TABLE 65 CHINA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 70

TABLE 66 INDIA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 71

TABLE 67 INDIA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 71

TABLE 68 INDIA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 72

TABLE 69 JAPAN NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 72

TABLE 70 JAPAN NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 73

TABLE 71 JAPAN NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 73

TABLE 72 SOUTH KOREA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 74

TABLE 73 SOUTH KOREA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 74

TABLE 74 SOUTH KOREA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 75

TABLE 75 AUSTRALIA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 75

TABLE 76 AUSTRALIA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 76

TABLE 77 AUSTRALIA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 76

TABLE 78 REST OF ASIA-PACIFIC NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 77

TABLE 79 REST OF ASIA-PACIFIC NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 77

TABLE 80 REST OF ASIA-PACIFIC NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 78

TABLE 81 MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY REGIONS USD MILLION (2020–2027) 79

TABLE 82 MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 80

TABLE 83 MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 80

TABLE 84 MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 81

TABLE 85 UAE NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 81

TABLE 86 UAE NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 82

TABLE 87 UAE NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 82

TABLE 88 SAUDI ARABIA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 83

TABLE 89 SAUDI ARABIA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 83

TABLE 90 SAUDI ARABIA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 84

TABLE 91 OMAN NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 84

TABLE 92 OMAN NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 85

TABLE 93 OMAN NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 85

TABLE 94 KUWAIT NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 86

TABLE 95 KUWAIT NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 86

TABLE 96 KUWAIT NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 87

TABLE 97 QATAR NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 87

TABLE 98 QATAR NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 88

TABLE 99 QATAR NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 88

TABLE 100 REST OF MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020–2027) 89

TABLE 101 REST OF MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020–2027) 89

TABLE 102 REST OF MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020–2027) 90

15 List Of Figures

FIGURE 1 GLOBAL NERVE STIMULATOR MARKET SHARE ANALYSIS BY TYPE, MARKET SHARE 2020 (%) 12

FIGURE 2 GLOBAL NERVE STIMULATOR MARKET SHARE ANALYSIS BY APPLICATION, MARKET SHARE 2020 (%) 12

FIGURE 3 MARKET STRUCTURE 14

FIGURE 4 RESEARCH PROCESS 15

FIGURE 5 VALUE CHAIN: NERVE STIMULATORS 29

FIGURE 6 GLOBAL NERVE STIMULATOR MARKET: BY TYPE USD MILLION (2020 & 2027) 33

FIGURE 7 GLOBAL NERVE STIMULATOR MARKET: FOR VAGUS NERVE STIMULATOR (VNS) USD MILLION (2020–2027) 34

FIGURE 8 GLOBAL NERVE STIMULATOR MARKET: BY APPLICATIONS USD MILLION (2020 & 2027) 36

FIGURE 9 GLOBAL NERVE STIMULATOR MARKET: BY END USER USD MILLION (2020 & 2027) 40

FIGURE 10 GLOBAL NERVE STIMULATOR MARKET: BY REGIONS USD MILLION (2020 & 2027) 43

FIGURE 11 AMERICAS NERVE STIMULATOR MARKET: BY REGIONS MARKET SHARE 2020 (%) 44

FIGURE 12 EUROPE NERVE STIMULATOR MARKET: BY REGIONS MARKET SHARE 2020 (%) 52

FIGURE 13 ASIA PACIFIC NERVE STIMULATOR MARKET: BY REGIONS MARKET SHARE 2020 (%) 67

FIGURE 14 MIDDLE EAST & AFRICA NERVE STIMULATOR MARKET: BY REGIONS MARKET SHARE 2020 (%) 79

FIGURE 15 GLOBAL NERVE STIMULATOR COMPANY MARKET SHARE 2020 (%) 91

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid